Scopulariopsis

(redirected from Scopulariopsis brevicaulis)

Scopulariopsis

(skō'pyū-lar'ē-op'sis),
A genus of filamentous fungi rarely pathogenic for humans; several species have been implicated in onychomycosis, ulcerating granuloma, and other "mycotic" entities. Penicillium-like, it is common in nature and generally a contaminant in laboratory cultures of human tissues.
[Mod. L. scopula, a small broom, + G. opsis, appearance]
References in periodicals archive ?
(13) In that study, all 59 cases of onychomycosis due to NDM resulted from the following fungi: Scopulariopsis brevicaulis, Fusarium, Acremonium, or Aspergillus.
krusei) (2) and non-dermatophyte molds (3), such as Scopulariopsis brevicaulis, Onychocola canadensis, Scytalidium spp., Fu-sarium spp., Aspergillus spp., and many others (4,5).
The wealth and abundance of organisms were determined and found dermatophytes 27%, non-dermatophytes 49% and yeasts 24%, corresponding to: Candida albicans 17% (9), Candida glabrata 6% (3), Trichophyton mentagrophytes 8% (4), Trichophyton rubrum 4% (2), Trichophyton tonsurans 6% (3), Microsporum canis 6% (3), Scopulariopsis brevicaulis 12% (6), Fusarium solani 19% (10), Penicillium sp.
Cladosporium spp., Alternaria spp., Fusarium spp., and Scopulariopsis brevicaulis were other most commonly isolated non-dermatophyte molds recorded in our study.
Activity of Scopulariopsis brevicaulis on Hyalomma anatolicum and Amblyomma lepidum (Acari: Ixodidae).
GOST 9.048-89 recommends the application of 8 different fungi (Aspergillus niger, Aspergillus terreus, Aureobasidium pullulans, Paecilomyces variotii, Penicillium funiculosum, Penicillium ochrochloron, Scopulariopsis brevicaulis, and Trichoderma viride) to test alteration of concrete strength.
The company is recalling the products because it has been found to have been contaminated with a microbe named Scopulariopsis brevicaulis. The problem was identified at the time of sample preparation for the Antimicrobial Preservative Effectiveness Testing, which was conducted as part of the 12-month stability study interval.
7 -- 7 (29.1) Scopulariopsis brevicaulis 4 -- 4 (16.6) Penicillium sp.
Annadurai, "Secretion of keratinolytic enzymes and keratinolysis by Scopulariopsis brevicaulis and Trichophyton mentagrophytes: regression analysis," Canadian Journal of Microbiology, vol.
Itraconazole has recently been reported to be effective in nail infections caused by Aspergillus, Fusarium and Scopulariopsis brevicaulis with mycological and clinical cure rate upto about 88%.